Carbone, Maria Vittoria
 Distribuzione geografica
Continente #
NA - Nord America 254
EU - Europa 186
AS - Asia 66
SA - Sud America 1
Totale 507
Nazione #
US - Stati Uniti d'America 253
SE - Svezia 58
IT - Italia 50
CN - Cina 27
IE - Irlanda 23
SG - Singapore 21
DE - Germania 13
FR - Francia 11
RU - Federazione Russa 11
GB - Regno Unito 6
IN - India 6
IR - Iran 6
KR - Corea 4
NL - Olanda 3
RO - Romania 3
CZ - Repubblica Ceca 2
ES - Italia 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
CA - Canada 1
CH - Svizzera 1
FI - Finlandia 1
HR - Croazia 1
Totale 507
Città #
Chandler 67
Ashburn 48
Dublin 23
New York 20
Rome 17
Beijing 12
Singapore 12
Moscow 9
Milan 7
Princeton 7
Washington 6
San Mateo 5
Boston 4
Busto Arsizio 4
Leawood 4
New Haven 4
Wilmington 4
Amsterdam 3
Asti 3
Jeju City 3
Los Angeles 3
Norwalk 3
Tehran 3
Bari 2
Bremen 2
Böblingen 2
Guidonia Montecelio 2
Kocaeli 2
Madrid 2
Marseille 2
Nave 2
Osimo 2
Paris 2
Sassari 2
Zanjan 2
Andover 1
Antwerp 1
Ardabil 1
Atlanta 1
Augusta 1
Bern 1
Bhandup 1
Boardman 1
Brasov 1
Brdo 1
Brno 1
Cambridge 1
Cattolica 1
Falkenstein 1
Iasi 1
Lappeenranta 1
Mattinata 1
Millbury 1
Mumbai 1
Munich 1
Perugia 1
Portland 1
Pune 1
Redmond 1
Redwood City 1
Rio de Janeiro 1
Sacramento 1
Sandston 1
Seattle 1
Suyeong-gu 1
Tampa 1
Tappahannock 1
Timisoara 1
Toronto 1
Vienna 1
Villamagna 1
Zagreb 1
Totale 332
Nome #
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 58
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 58
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 58
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 56
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 45
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 33
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 32
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach 31
Isolated humeral metastasis in cervical cancer: A case report and review of the literature 28
PARP Inhibitors Resistance: Mechanisms and Perspectives 25
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 22
Recent progress in the use of pharmacotherapy for endometrial cancer 22
Advanced and recurrent endometrial cancer: State of the art and future perspectives 17
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 16
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 13
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 7
Genome tumor profiling in endometrial cancer and clinical relevance in endometrial cancer management: A retrospective single-center experience 4
Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer 4
Totale 529
Categoria #
all - tutte 3.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 2 2 5 8 11 0
2021/202277 8 1 2 17 3 1 1 7 2 5 11 19
2022/2023185 19 22 12 30 8 20 2 5 21 19 22 5
2023/2024228 3 41 23 18 6 36 30 9 7 9 20 26
2024/202511 9 2 0 0 0 0 0 0 0 0 0 0
Totale 529